Provided by Tiger Trade Technology Pte. Ltd.

Dianthus Therapeutics Inc.

106.24
-0.3800-0.36%
Post-market: 106.240.00000.00%19:30 EDT
Volume:565.39K
Turnover:59.98M
Market Cap:5.94B
PE:-25.83
High:110.44
Open:107.69
Low:103.13
Close:106.62
52wk High:117.88
52wk Low:23.39
Shares:55.93M
Float Shares:55.85M
Volume Ratio:1.20
T/O Rate:1.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1130
EPS(LYR):-4.2037
ROE:-26.07%
ROA:-17.69%
PB:5.07
PE(LYR):-25.27

Loading ...

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Apr 07

Dianthus CFO Ryan Savitz disposes of DNTH common shares worth $9.1 million

Reuters
·
Apr 02

Dianthus Therapeutics director Paula Soteropoulos disposes of shares worth $0 million

Reuters
·
Apr 02

Wells Fargo Remains a Buy on Dianthus Therapeutics (DNTH)

TIPRANKS
·
Apr 01

Dianthus Therapeutics (DNTH) Receives a Buy from Wells Fargo

TIPRANKS
·
Mar 27

Dianthus Therapeutics; Director Paula Soteropoulos drops 27,594 common shares worth $2,153,736

Reuters
·
Mar 27

Dianthus Therapeutics- Proposed Changes to Screening Criteria Related to Claseprubart Trials to FDA in Q1 2026 - SEC Filing

THOMSON REUTERS
·
Mar 26

U.S. RESEARCH ROUNDUP-Carnival, Five Below, McKesson

Reuters
·
Mar 19

Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH) and Minerva Neurosciences (NERV)

TIPRANKS
·
Mar 16

Dianthus Chief Accounting Officer Edward Carr Disposes of Common Shares

Reuters
·
Mar 14

Dianthus price target raised to $103 from $80 at Wedbush

TIPRANKS
·
Mar 12

Analysts Have Conflicting Sentiments on These Healthcare Companies: Nanobiotix (NBTX), ImageneBio (IMA) and Dianthus Therapeutics (DNTH)

TIPRANKS
·
Mar 12

Dianthus Therapeutics prices upsized follow-on offering at USD 625 million

Reuters
·
Mar 11

Dianthus Therapeutics Inc - Prices Upsized Offering of 7,313,582 Shares at $81.00 per Share

THOMSON REUTERS
·
Mar 11

Stock Track | Dianthus Therapeutics Soars 5.09% Intraday on Multiple Analyst Upgrades and Price Target Increases

Stock Track
·
Mar 11

Dianthus price target raised to $80 from $55 at Wedbush

TIPRANKS
·
Mar 10

Dianthus Therapeutics Inc : Raymond James Raises to Strong Buy From Outperform; Raises Target Price to $123 From $63

THOMSON REUTERS
·
Mar 10

U.S. RESEARCH ROUNDUP-Adobe, Caseys General Stores, FedEx

Reuters
·
Mar 10

AI Integration Exposes Dianthus Therapeutics to Heightened Cyber, Privacy, and Reputational Risks

TIPRANKS
·
Mar 10

BRIEF-Dianthus Therapeutics Announces Proposed $400 Million Underwritten Public Offering

Reuters
·
Mar 10